Veradermics, Incorporated

Price Chart

Risk-Adjusted Performance

Veradermics, Incorporated (MANE) Price Performance

Veradermics, Incorporated (MANE) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $63.49, up 7.81% from the previous close.

Over the past year, MANE has traded between a low of $37.03 and a high of $63.49. The stock has gained 68.2% over this period. It is currently 71.5% above its 52-week low.

Veradermics, Incorporated has a market capitalization of $2.23B.

About Veradermics, Incorporated

Veradermics, Incorporated operates as a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was founded in 2019 and is based in New Haven, Connecticut.